Biotage AB (publ) publishes its 2015 Annual Report and Corporate Governance Report and Financial Goals for the period 2016 – 2018

Biotage’s 2015 Annual Report and Corporate Governance Report are as of today
available at: www.biotage.com

Biotage have two financial targets in its business; an organic sales growth
target of 8 percent and an EBIT margin target of 10 percent. The targets are
formulated as an average for the three-year period 2016 – 2018.


Biotage discloses the information provided herein pursuant to the Swedish
Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The
information was submitted for publication at 09.00 on 22 March 2016.


Contact persons:
Torben Jörgensen, CEO
Tel: 0707-49 05 84, torben.jorgensen@biotage.com
Erika Söderberg-Johnson, CFO
Tel: 0707-20 48 20, erika.soderberg-johnson@biotage.com


About Biotage
Biotage offers efficient separation technologies from analysis to industrial
scale and high quality solutions for analytical chemistry from research to
commercial analysis laboratories. Biotage’s products are used by government
authorities, academic institutions, pharmaceutical and food companies, among
others. The company is headquartered in Uppsala and has offices in the US, UK,
China and Japan. Biotage has approx. 290 employees and had sales of 610 MSEK in
2015. Biotage is listed on the NASDAQ OMX Stockholm stock exchange. Website:
www.biotage.com